News

Massive hope for pancreatic cancer pill after trial saw tumours vanish

CO

Experts are calling it the biggest breakthrough in pancreatic cancer treatment for decades - a daily pill that appears to shrink and possibly even eliminate tumours in some patients with one of the deadliest and hardest-to-treat cancers. Cancer became undetectable on scans in one in 12 of the patients given daraxonrasib along with chemotherapy in early medical trials. Tumours stopped growing in almost all of the 61 participants who had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body. But doctors stress it is unclear how long it might keep the disease at bay and should not be seen as a cure. Cancer Research UK called it "the biggest leap forward in decades" for pancreatic cancer patients.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.